Haemonetics has agreed to purchase blood transfusion devices and operations from Pall. The $550 million deal could be finalized this summer. Haemonetics has also agreed to pay $27 million to acquire Hemerus Medical, a developer of blood collection, processing and storage technology. The price is dependent on the FDA's review of Hemerus' SOLX blood collection system.

Related Summaries